Research ArticleOriginal Research

Family Physicians' Barriers and Facilitators in Incorporating Medication Abortion

Na'amah Razon, Sarah Wulf, Citlali Perez, Sarah McNeil, Lisa Maldonado, Alison Byrne Fields, Kelsey Holt, Edith Fox, Ilana Silverstein and Christine Dehlendorf
The Journal of the American Board of Family Medicine May 2022, 35 (3) 579-587; DOI: https://doi.org/10.3122/jabfm.2022.03.210266

References

  1. 1.↵
    1. Jones RK,
    2. Witwer E,
    3. Jerman J
    . Abortion Incidence and Service Availability the United States, 2017.; 2019. Abortion Incidence and Service Availability in the United States, 2017.
  2. 2.↵
    1. Espey E,
    2. Leeman L,
    3. Ogburn T,
    4. Skipper B,
    5. Eyman C,
    6. North M
    . Has mifepristone medical abortion expanded abortion access in New Mexico? A survey of OB-GYN and Family Medicine physicians. Contraception 2011;84:178–83.
    OpenUrl
  3. 3.↵
    1. Freedman L,
    2. Landy U,
    3. Darney P,
    4. Steinauer J
    . Obstacles to the integration of abortion into obstetrics and gynecology practice. Perspect Sex Reprod Health 2010;42:146–51.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Munro S,
    2. Guilbert E,
    3. Wagner MS,
    4. et al
    . Perspectives among canadian physicians on factors influencing implementation of mifepristone medical abortion: A national qualitative study. Ann Fam Med 2020;18:413–21.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Rowlands S,
    2. López-Arregui E
    , Expert Group on Abortion, European Society of Contraception and Reproductive Health. How health services can improve access to abortion. Eur J Contracept Reprod Health Care 2016;21:1–3.
    OpenUrl
  6. 6.↵
    1. Darney BG,
    2. Weaver MR,
    3. Stevens N,
    4. Kimball J,
    5. Prager SW
    . Management: impact on practice in Washington state., Fam Med 2013;45:102–8.
    OpenUrl
  7. 7.↵
    1. Nothnagle M,
    2. Prine L,
    3. Goodman S
    . Benefits of comprehensive reproductive health education in family medicine residency. Fam Med 2008;40:204–7.
    OpenUrlPubMed
  8. 8.↵
    1. Beaman J,
    2. Schillinger D
    . Beaman_responding to evolving abortion regulations2019.pdf. N Engl J Med 2019;380:e30.
    OpenUrl
  9. 9.↵
    1. Rubin SE,
    2. Godfrey E,
    3. Gold M
    . Patient attitudes toward early abortion services in the family medicine clinic. J Am Board Fam Med 2008;21:162–4.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Prine L,
    2. Lesnewski R
    . Medication abortion and family physicians' scope of practice. Journal of the American Board of Fam Med. 2005;18(4)304–6.
    OpenUrl
  11. 11.↵
    1. Prine L,
    2. Lesnewski R,
    3. Berley N,
    4. Gold M
    . Medical abortion in family practice: a case series. J Am Board Fam Pract 2003;16:290–5.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Burns M,
    2. Rochat R,
    3. Bryant AG,
    4. Andersen K
    . Is abortion included in maternal and child health curricula in the United States? Matern Child Health J 2018;22:1556–62.
    OpenUrl
  13. 13.↵
    1. Grossman D,
    2. Grindlay K,
    3. Altshuler AL,
    4. Schulkin J
    . Induced abortion provision among a national sample of obstetrician-gynecologists. Obstet Gynecol 2019;133:477–83.
    OpenUrl
  14. 14.↵
    1. Dehlendorf C,
    2. Brahmi D,
    3. Engel D,
    4. Grumbach K,
    5. Joffe C,
    6. Gold M
    . Integrating abortion training into family medicine residency programs. Fam Med 2007;39:337–42.
    OpenUrlPubMedWeb of Science
  15. 15.↵
    1. Greenberg M
    . Barriers and enablers to becoming abortion providers. Fam Med 2017;44:493–500.
    OpenUrl
  16. 16.↵
    1. Goodman S,
    2. Shih G,
    3. Hawkins M,
    4. et al.
    ,. A long-term evaluation of a required reproductive health training rotation with opt-out provisions for family medicine residents. Fam Med 2013;45:180–6.
    OpenUrl
  17. 17.↵
    1. Kaye J,
    2. Reeves R,
    3. Chaiten L
    . The mifepristone REMS: A needless and unlawful barrier to care. Contraception 2021;104:12–5.
    OpenUrlPubMed
  18. 18.↵
    1. Raymond EG,
    2. Blanchard K,
    3. Blumenthal PD
    , Mifeprex REMS Study Group, et al. Sixteen years of overregulation: time to unburden Mifeprex. N Engl J Med 2017;376:790–4.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Ajzen I
    . The theory of planned behavior. Organizational Behavior and Human Decision Processes 1991;50:179–211.
    OpenUrlCrossRefWeb of Science
  20. 20.↵
    1. Hsieh HF,
    2. Shannon SE
    . Three approaches to qualitative content analysis. Published online 2005.
  21. 21.↵
    1. Nash E
    . State Abortion Policy Landscape: From Hostile to Supportive. Guttmacher Institute; 2019. https://www.guttmacher.org/article/2019/08/state-abortion-policy-landscape-hostile-supportive.
  22. 22.↵
    1. Patel P,
    2. Narayana S,
    3. Thill Z,
    4. Gold M,
    5. Paul A
    . Family physicians' role in simplifying medication abortion during the COVID-19 pandemic. J Am Board Fam Med 2021;34:S33–S36.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Coffman M,
    2. Wilkinson E,
    3. Jabbarpour Y
    . Despite adequate training, only half of family physicians provide women's health care services. J Am Board Fam Med 2020;33:186–8.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Chelvakumar M,
    2. Shaw J
    . Trained and ready, but not serving?—family physicians' role in reproductive health care. J Am Board Fam Med 2020;33:182–5.
    OpenUrlFREE Full Text
  25. 25.↵
    1. Kumar V,
    2. Herbitter C,
    3. Karasz A,
    4. Gold M
    . Being in the room: reflections on pregnancy options counseling during abortion training. Fam Med 2010;42:41–6.
    OpenUrlPubMed
  26. 26.↵
    1. Herbitter C,
    2. Bennett A,
    3. Schubert FD,
    4. Bennett IM,
    5. Gold M
    . Management of early pregnancy failure and induced abortion by family medicine educators. J Am Board Fam Med 2013;26:751–8.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Calloway D,
    2. Stulberg D,
    3. Janiak E
    . Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States. Contraception 2021;104:24–8.
    OpenUrl
  28. 28.↵
    Reproductive Health Access Project. Frequently asked questions about integrating medication abortion care into community health centers. Published September 2019. Accessed June 30, 2021.
  29. 29.↵
    1. Jabbarpour Y,
    2. Westfall J
    . Diversity in the family medicine workforce. Fam Med 2021;53:640–3.
    OpenUrlCrossRef
  30. 30.↵
    1. Peabody MR,
    2. Eden AR,
    3. Douglas M,
    4. Phillips RL
    . Board certified family physician workforce: progress in racial and ethnic diversity. J Am Board Fam Med 2018;31:842–3.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    Association of the American Medical Colleges (AAMC). Diversity in Medicine: Facts and Figures 2019. Accessed October 5, 2021. https://www.aamc.org/data-reports/workforce/interactive-data/figure-18-percentage-all-active-physicians-race/ethnicity-2018.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords